Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Mr. Andrew T. ReardonChief Legal Officer & Secretary | -5.00k | 873.97k | Derivative Exercise and Sale | 52.27 - 230.41 | 41.38k | - |
| 2026-05-01 | Dr. John Warren KozarichIndependent Chairman | -467.00 | 108.25k | Automatic Disposition | 227.37 - 234.09 | 40.58k | -1.14% |
| 2026-05-12 | Dr. John Warren KozarichIndependent Chairman | -2.03k | 313.45k | Derivative Exercise and Sale | 69.51 - 224.00 | 40.58k | - |
| 2026-05-01 | Mr. Andrew T. ReardonChief Legal Officer & Secretary | -5.00k | 895.21k | Derivative Exercise and Sale | 52.27 - 234.02 | 41.38k | - |
| 2026-04-01 | Dr. John Warren KozarichIndependent Chairman | -467.00 | 94.44k | Automatic Disposition | 199.97 - 204.26 | 41.04k | -1.13% |
| 2026-04-01 | Mr. Andrew T. ReardonChief Legal Officer & Secretary | -5.00k | 744.87k | Derivative Exercise and Sale | 52.27 - 204.50 | 41.38k | - |
| 2026-03-06 | Dr. John L. LaMattinaIndependent Director | -2.16k | 187.16k | Derivative Exercise and Sale | 114.15 - 200.76 | 29.52k | - |
| 2026-03-23 | Dr. Stephen Lawrence SabbaIndependent Director | -1,000.00 | 207.87k | 売り | 207.87 | 31.58k | -3.07% |
| 2026-03-11 | Mr. Octavio EspinozaCFO | -2.41k | 318.30k | Derivative Exercise and Sale | 92.65 - 225.00 | 21.01k | - |
| 2026-03-11 | Mr. Octavio EspinozaCFO | -652.00 | 146.70k | Automatic Disposition | 225.00 | 21.01k | -3.01% |
| 2026-03-04 | Mr. Andrew T. ReardonChief Legal Officer & Secretary | -5.00k | 770.42k | Derivative Exercise and Sale | 52.27 - 208.87 | 36.87k | - |
| 2026-03-04 | Mr. Octavio EspinozaCFO | -2.07k | 283.93k | Derivative Exercise and Sale | 58.49 - 201.73 | 21.66k | - |
| 2026-03-04 | Mr. Octavio EspinozaCFO | -11.35k | 2.35M | Automatic Disposition | 201.73 - 208.80 | 21.66k | -34.38% |
| 2026-03-03 | Dr. Stephen Lawrence SabbaIndependent Director | -2.03k | 268.47k | Derivative Exercise and Sale | 69.51 - 201.50 | 32.58k | - |
| 2026-03-02 | Dr. John Warren KozarichIndependent Chairman | -467.00 | 93.63k | Automatic Disposition | 197.14 - 203.57 | 41.51k | -1.11% |
| 2026-02-14 | Mr. Andrew T. ReardonChief Legal Officer & Secretary | -9.68k | 1.78M | Sale to Issuer | 183.83 | 36.87k | -20.80% |
| 2026-02-14 | Mr. Octavio EspinozaCFO | -11.76k | 2.16M | Sale to Issuer | 183.83 | 33.01k | -26.27% |
| 2026-02-14 | Mr. Todd C. DavisCEO & Director | -32.88k | 6.04M | Sale to Issuer | 183.83 | 163.82k | -16.71% |
| 2026-02-02 | Dr. John Warren KozarichIndependent Chairman | -467.00 | 91.49k | Automatic Disposition | 191.00 - 197.20 | 41.98k | -1.10% |
| 2026-01-02 | Dr. John Warren KozarichIndependent Chairman | -467.00 | 88.53k | Automatic Disposition | 186.59 - 192.40 | 42.45k | -1.09% |
| 2025-12-16 | Mr. Octavio EspinozaCFO | 2.38k | 164.30k | Derivative Exercise and Retained Stock | 52.84 - 103.42 | 28.57k | 9.09% |
| 2025-12-12 | Mr. Octavio EspinozaCFO | -1.80k | 339.71k | 売り | 188.31 | 26.19k | -6.45% |
| 2025-12-05 | Mr. Octavio EspinozaCFO | -1.86k | 344.23k | Sale to Issuer | 184.87 | 27.99k | -6.24% |
| 2025-12-04 | Mr. Todd C. DavisCEO & Director | -130.00 | 0.00 | Other Disposition | - | 112.66k | -0.12% |
| 2025-12-08 | Mr. Jason M. AryehIndependent Director | 2.03k | 141.38k | Derivative Exercise and Retained Stock | 69.51 | 75.14k | 2.78% |
| 2025-12-01 | Dr. John Warren KozarichIndependent Chairman | -467.00 | 91.46k | Automatic Disposition | 193.86 - 200.02 | 42.91k | -1.08% |
| 2025-11-07 | Dr. John L. LaMattinaIndependent Director | -4.18k | 575.34k | Derivative Exercise and Sale | 66.13 - 205.45 | 29.52k | - |
| 2025-11-07 | Dr. Nancy Ryan GrayIndependent Director | -6.57k | 892.83k | Derivative Exercise and Sale | 66.19 - 205.45 | 6.89k | - |
| 2025-11-03 | Dr. John Warren KozarichIndependent Chairman | -467.00 | 89.22k | Automatic Disposition | 189.00 - 192.38 | 43.38k | -1.07% |
| 2025-10-01 | Dr. John Warren KozarichIndependent Chairman | -467.00 | 83.80k | Automatic Disposition | 177.60 - 181.18 | 43.85k | -1.05% |
| 2025-09-22 | Dr. Martine ZimmermannIndependent Director | -115.00 | 19.64k | Sale to Issuer | 170.77 | - | - |
| 2025-09-23 | Mr. Jason M. AryehIndependent Director | -10.00k | 1.71M | 売り | 170.41 - 171.92 | 73.11k | -12.03% |
| 2025-09-02 | Dr. John Warren KozarichIndependent Chairman | -467.00 | 75.77k | Automatic Disposition | 161.51 - 164.25 | 44.31k | -1.04% |
| 2025-08-10 | Mr. Andrew T. ReardonChief Legal Officer & Secretary | -1.33k | 198.83k | Sale to Issuer | 150.06 | 30.81k | -4.12% |
| 2025-08-01 | Dr. John Warren KozarichIndependent Chairman | -467.00 | 61.59k | Automatic Disposition | 131.88 | 44.78k | -1.03% |
| 2025-07-10 | Dr. John Warren KozarichIndependent Chairman | -934.00 | 116.75k | Automatic Disposition | 125.00 | 45.25k | -2.02% |
| 2025-06-23 | Mr. Andrew T. ReardonChief Legal Officer & Secretary | -500.00 | 57.04k | 売り | 114.08 | 31.90k | -1.54% |
| 2025-06-10 | Mr. Andrew T. ReardonChief Legal Officer & Secretary | -500.00 | 57.27k | 売り | 114.54 | 32.40k | -1.52% |
| 2025-06-06 | Dr. Martine ZimmermannIndependent Director | -188.00 | 19.93k | Sale to Issuer | 105.99 | - | - |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。